These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36717819)
1. Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma. Zhang GT; Liu Q; Zuo FX; Liu HJ; Wang SQ; Yuan Q; Liu AS; Hu K; Meng XL; Wang WJ; Qian HP; Wan JH; Cai HQ BMC Cancer; 2023 Jan; 23(1):104. PubMed ID: 36717819 [TBL] [Abstract][Full Text] [Related]
2. Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018. Dadey DYA; Medress ZA; Sharma M; Ugiliweneza B; Wang D; Rodrigues A; Parker J; Burton E; Williams B; Han SS; Boakye M; Skirboll S J Neurooncol; 2023 Sep; 164(3):655-662. PubMed ID: 37792220 [TBL] [Abstract][Full Text] [Related]
3. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study. Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077 [TBL] [Abstract][Full Text] [Related]
4. Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell Carcinoma. Sun G; Zhang X; Liang J; Pan X; Zhu S; Liu Z; Armstrong CM; Chen J; Lin W; Liao B; Lin T; Huang R; Zhang M; Zheng L; Yin X; Nie L; Shen P; Zhao J; Zhang H; Dai J; Shen Y; Li Z; Liu J; Chen J; Liu J; Wang Z; Zhu X; Ni Y; Qin D; Yang L; Chen Y; Wei Q; Li X; Zhou Q; Huang H; Yao J; Chen N; Zeng H Clin Cancer Res; 2021 Mar; 27(6):1734-1743. PubMed ID: 33414138 [TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma]. Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864 [No Abstract] [Full Text] [Related]
6. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling. Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388 [TBL] [Abstract][Full Text] [Related]
7. Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma. Bacon JVW; Annala M; Soleimani M; Lavoie JM; So A; Gleave ME; Fazli L; Wang G; Chi KN; Kollmannsberger CK; Wyatt AW; Nappi L Clin Genitourin Cancer; 2020 Aug; 18(4):322-331.e2. PubMed ID: 32046920 [TBL] [Abstract][Full Text] [Related]
8. Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course. DiNatale RG; Gorelick AN; Makarov V; Blum KA; Silagy AW; Freeman B; Chowell D; Marcon J; Mano R; Sanchez A; Attalla K; Weng S; Voss M; Motzer RJ; Russo P; Coleman JA; Reuter VE; Chen YB; Chan TA; Reznik E; Tickoo SK; Hakimi AA Eur Urol Focus; 2021 Mar; 7(2):381-389. PubMed ID: 31813809 [TBL] [Abstract][Full Text] [Related]
9. The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival. Shu C; Wang Q; Yan X; Wang J Cancer Med; 2018 Aug; 7(8):3704-3712. PubMed ID: 29984907 [TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation]. Jiang Y; Su G; Yu W; Li J; Lu Q; Li Y; Zhang W Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):823-6. PubMed ID: 26887511 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma. Moss TJ; Qi Y; Xi L; Peng B; Kim TB; Ezzedine NE; Mosqueda ME; Guo CC; Czerniak BA; Ittmann M; Wheeler DA; Lerner SP; Matin SF Eur Urol; 2017 Oct; 72(4):641-649. PubMed ID: 28601352 [TBL] [Abstract][Full Text] [Related]
13. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture. Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic Features and Prognosis of Sporadic Bilateral Renal Cell Carcinoma: A Series of 148 Cases. Qi N; Li T; Ning X; Peng X; Cai L; Gong K Clin Genitourin Cancer; 2017 Oct; 15(5):618-624. PubMed ID: 28648756 [TBL] [Abstract][Full Text] [Related]
15. [Renal cell carcinoma in patients with end-stage renal disease: a clinicopathological analysis]. He B; Zhang W; Liu LN; Wang H; Zou YW; Jiang YX; Yu WJ; Shi HL; Liu Y; Li YJ Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):846-850. PubMed ID: 31775432 [No Abstract] [Full Text] [Related]
16. Analysis of clinicopathological and molecular features of ELOC(TCEB1)-mutant renal cell carcinoma. Wang Y; Zhao P; Wang L; Wang J; Ji X; Li Y; Shi H; Li Y; Zhang W; Jiang Y Pathol Res Pract; 2022 Jul; 235():153960. PubMed ID: 35653922 [TBL] [Abstract][Full Text] [Related]
17. Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population. Zhang S; Wang B; Zhang F; Ye J; Ge L; Ma L Med Sci Monit; 2019 Apr; 25():2959-2965. PubMed ID: 31007253 [TBL] [Abstract][Full Text] [Related]
18. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity. Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909 [TBL] [Abstract][Full Text] [Related]
19. The genomics of renal cell carcinoma and its role in renal mass biopsy. Salami SS; George AK; Udager AM Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of extensive necrosis in renal cell carcinoma. Collins J; Epstein JI Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]